Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qiangke in Moderate to Severe Plaque Psoriasis
NCT02701205Phase 3Unknown
- Sponsor
- Shanghai Celgen Biopharma
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of Qiangke in plaque psoriasis, sponsored by Shanghai Celgen Biopharma. Status: unknown.
02
Drugs
Qiangke
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02701205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02701205.